Toronto, Ontario, Canada (PRWEB) February 23, 2009
Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd. Under the agreement Dalton will continue to provide chemistry services in support of Boehringer's pharmaceutical development programs.
Peter Pekos, President of Dalton Pharma Services, said: "We are extremely pleased to continue our relationship with Boehringer Ingelheim (Canada) Ltd. The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim's deep commitment to research in Canada. We look forward to another successful collaboration with this world class organization."
About Dalton Pharma Services:
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, medicinal chemistry and analytical services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry, fine chemical manufacture, custom peptides and antisense oligo production. Dalton provides cGMP manufacturing and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton can produce active pharmaceutical ingredients (API), at the gram or kilogram scale. Dalton can carry out sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton's analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.
Dalton Pharma Services
ppekos (at) dalton (dot) com